Investigational New Drugs, Journal Year: 2025, Volume and Issue: unknown
Published: April 28, 2025
Language: Английский
Investigational New Drugs, Journal Year: 2025, Volume and Issue: unknown
Published: April 28, 2025
Language: Английский
Metabolites, Journal Year: 2025, Volume and Issue: 15(5), P. 286 - 286
Published: April 23, 2025
Alterations in sympathetic nervous activity are evident response to changes body weight. Sympathetic and responses weight change regionalized, with alterations end organ function dependent on the occurring brain regulatory pathways invoked effector organs engaged. The obesity-induced activation of system likely contributes initiation worsening cardiometabolic risk factors, including elevated blood pressure, cardiac dysfunction, dyslipidaemia, increased fasting glucose, insulin resistance, non-alcoholic steatohepatitis. Unintended loss, as occurs cachexia, is driven, at least part, by nervous-stimulated thermogenesis. complexity regulation renders use global measures problematic development targeted therapies difficult, but these not without promise or precedent. Knowledge central peripheral involved has opened up opportunities for pharmacological, surgical, device-based approaches mitigating burden disease progression. In this narrative review, we elaborate weight, involved, cardiovascular metabolic risks associated perturbations regional activity.
Language: Английский
Citations
0Investigational New Drugs, Journal Year: 2025, Volume and Issue: unknown
Published: April 28, 2025
Language: Английский
Citations
0